Cheng H - Search Results

1

Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling.

Peng Y, Kang Q, Cheng H, Li X, Sun MH, Jiang W, Luu HH, Park JY, Haydon RC, He TC. Peng Y, et al. Among authors: cheng h. J Cell Biochem. 2003 Dec 15;90(6):1149-65. doi: 10.1002/jcb.10744. J Cell Biochem. 2003. PMID: 14635189

2

Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs).

Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, Luu HH, An N, Breyer B, Vanichakarn P, Szatkowski JP, Park JY, He TC. Cheng H, et al. J Bone Joint Surg Am. 2003 Aug;85(8):1544-52. doi: 10.2106/00004623-200308000-00017. J Bone Joint Surg Am. 2003. PMID: 12925636

3

Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma.

Haydon RC, Zhou L, Feng T, Breyer B, Cheng H, Jiang W, Ishikawa A, Peabody T, Montag A, Simon MA, He TC. Haydon RC, et al. Among authors: cheng h. Clin Cancer Res. 2002 May;8(5):1288-94. Clin Cancer Res. 2002. PMID: 12006550 Free PMC article.

4

Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma.

Haydon RC, Deyrup A, Ishikawa A, Heck R, Jiang W, Zhou L, Feng T, King D, Cheng H, Breyer B, Peabody T, Simon MA, Montag AG, He TC. Haydon RC, et al. Among authors: cheng h. Int J Cancer. 2002 Dec 1;102(4):338-42. doi: 10.1002/ijc.10719. Int J Cancer. 2002. PMID: 12402302 Free PMC article.

5

Potential use of Sox9 gene therapy for intervertebral degenerative disc disease.

Paul R, Haydon RC, Cheng H, Ishikawa A, Nenadovich N, Jiang W, Zhou L, Breyer B, Feng T, Gupta P, He TC, Phillips FM. Paul R, et al. Among authors: cheng h. Spine (Phila Pa 1976). 2003 Apr 15;28(8):755-63. Spine (Phila Pa 1976). 2003. PMID: 12698117 Free PMC article.

6

Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity.

Zhou L, An N, Haydon RC, Zhou Q, Cheng H, Peng Y, Jiang W, Luu HH, Vanichakarn P, Szatkowski JP, Park JY, Breyer B, He TC. Zhou L, et al. Among authors: cheng h. Cancer Lett. 2003 Apr 25;193(2):161-70. doi: 10.1016/s0304-3835(03)00013-2. Cancer Lett. 2003. PMID: 12706873 Free PMC article.

7

Degree of carotid plaque calcification in relation to symptomatic outcome and plaque inflammation.

Shaalan WE, Cheng H, Gewertz B, McKinsey JF, Schwartz LB, Katz D, Cao D, Desai T, Glagov S, Bassiouny HS. Shaalan WE, et al. Among authors: cheng h. J Vasc Surg. 2004 Aug;40(2):262-9. doi: 10.1016/j.jvs.2004.04.025. J Vasc Surg. 2004. PMID: 15297819 Free article.

8

B-mode ultrasonographic characterization of carotid atherosclerotic plaques in symptomatic and asymptomatic patients.

Grogan JK, Shaalan WE, Cheng H, Gewertz B, Desai T, Schwarze G, Glagov S, Lozanski L, Griffin A, Castilla M, Bassiouny HS. Grogan JK, et al. Among authors: cheng h. J Vasc Surg. 2005 Sep;42(3):435-41. doi: 10.1016/j.jvs.2005.05.033. J Vasc Surg. 2005. PMID: 16171584 Free article.

9

Alkaline Hydrogen Evolution Reaction Electrocatalysts for Anion Exchange Membrane Water Electrolyzers: Progress and Perspective.

Zhu Y, Li L, Cheng H, Ma J. Zhu Y, et al. Among authors: cheng h. JACS Au. 2024 Nov 21;4(12):4639-4654. doi: 10.1021/jacsau.4c00898. eCollection 2024 Dec 23. JACS Au. 2024. PMID: 39735935 Free PMC article. Review.

10

Research hotspots and trends on NF-κB in cognitive impairment: a bibliometric analysis.

Bai L, Xu F, Hu P, Shen Z, Xingxing S, Wang Q, Cheng H. Bai L, et al. Among authors: cheng h. Front Med (Lausanne). 2024 Dec 12;11:1432455. doi: 10.3389/fmed.2024.1432455. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39735704 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,942 results

Search Page

Filters